Stay updated on Selinexor in Smoldering MM Clinical Trial
Sign up to get notified when there's something new on the Selinexor in Smoldering MM Clinical Trial page.

Latest updates to the Selinexor in Smoldering MM Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check35 days agoChange DetectedThe page has updated the name of a key individual from Jodi Lipof to Brea Lipe, and a date has been changed from October 17, 2023, to February 10, 2025.SummaryDifference1%
- Check42 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check49 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check71 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
Stay in the know with updates to Selinexor in Smoldering MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor in Smoldering MM Clinical Trial page.